ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » North Carolina » Geriatric Medicine

Top Geriatric Medicine Prescribers in North Carolina

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MARTIN JANIS MD

Geriatric Medicine

7,551

$448K

329
306 are 65+

11%
patients receiving schedule two controlled substances

Avg: 12%

13%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $58

JAMES PARSONS M.D.

Geriatric Medicine

7,322

$361K

364
341 are 65+

11%
patients receiving schedule two controlled substances

Avg: 12%

8%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $58

JODI SHAINBERG MD

Geriatric Medicine

7,228

$382K

355
289 are 65+

21%
patients receiving schedule two controlled substances

Avg: 12%

12%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $58

BHAIRAVI PATEL MD

Geriatric Medicine

6,526

$317K

465
405 are 65+

24%
patients receiving schedule two controlled substances

Avg: 12%

11%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $58

SHYAM GARG M.D.

Geriatric Medicine

6,194

$284K

263
177 are 65+

11%
patients receiving schedule two controlled substances

Avg: 12%

27%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$46
Average prescription price

Avg: $58

ADEBUKOLA TAIWO MD

Geriatric Medicine

5,994

$350K

205
190 are 65+

10%
patients receiving schedule two controlled substances

Avg: 12%

8%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$58
Average prescription price

Avg: $58

DEBRA WODECKI MD

Geriatric Medicine

5,882

$332K

233
94 are 65+

0%
patients receiving schedule two controlled substances

Avg: 12%

25%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $58

JOHN KIZER MD

Geriatric Medicine

5,724

$324K

237
204 are 65+

5%
patients receiving schedule two controlled substances

Avg: 12%

19%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $58

DARSHANA CHADDA D.O.

Geriatric Medicine

5,606

$306K

167
132 are 65+

0%
patients receiving schedule two controlled substances

Avg: 12%

8%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $58

TIFFANY REED D.O.

Geriatric Medicine

5,575

$309K

625
517 are 65+

35%
patients receiving schedule two controlled substances

Avg: 12%

16%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $58

KRISHNAMURTHY JONNALAGADDA M.D.

Geriatric Medicine

5,523

$316K

206
181 are 65+

22%
patients receiving schedule two controlled substances

Avg: 12%

8%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $58

FRANKLIN OHIAGBAJI M.D.

Geriatric Medicine

5,290

$380K

149
120 are 65+

14%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$72
Average prescription price

Avg: $58

MARSHA FRETWELL M.D.

Geriatric Medicine

5,245

$119K

220
200 are 65+

10%
patients receiving schedule two controlled substances

Avg: 12%

5%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 25%

$23
Average prescription price

Avg: $58

STEPHEN FRIEDMAN M.D.

Geriatric Medicine

4,889

$205K

205
196 are 65+

7%
patients receiving schedule two controlled substances

Avg: 12%

10%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$42
Average prescription price

Avg: $58

AMY COHEN M.D.

Geriatric Medicine

4,683

$207K

224
205 are 65+

26%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$44
Average prescription price

Avg: $58

DAVID HALPERN MD, MPH

Geriatric Medicine

4,600

$273K

300
249 are 65+

6%
patients receiving schedule two controlled substances

Avg: 12%

6%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $58

JOANNE HELPPIE M.D.

Geriatric Medicine

3,306

$184K

202
197 are 65+

0%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $58

ELIZABETH CASTILLO MD PHD

Geriatric Medicine

3,273

$152K

164
153 are 65+

23%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$46
Average prescription price

Avg: $58

SANGEETA VARANASI MD

Geriatric Medicine

3,255

$378K

321
310 are 65+

0%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 25%

$116
Average prescription price

Avg: $58

ELLEN KACZMAREK MD

Geriatric Medicine

3,099

$104K

115
114 are 65+

0%
patients receiving schedule two controlled substances

Avg: 12%

11%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$33
Average prescription price

Avg: $58

ANN LANSING MD

Geriatric Medicine

3,064

$155K

142
128 are 65+

20%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $58

KIMBERLY JOHNSON M.D.

Geriatric Medicine

2,885

$166K

73
61 are 65+

48%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$58
Average prescription price

Avg: $58

MARY LYLES MD

Geriatric Medicine

2,858

$139K

123
121 are 65+

0%
patients receiving schedule two controlled substances

Avg: 12%

9%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $58

GWENDOLEN BUHR M.D.

Geriatric Medicine

2,502

$167K

112
112 are 65+

16%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$67
Average prescription price

Avg: $58

AMOS PAGTER M.D.

Geriatric Medicine

2,441

$134K

96
90 are 65+

0%
patients receiving schedule two controlled substances

Avg: 12%

18%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $58

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank